Loading...

Lawrence Ang

TitleAssistant Clinical Professor
InstitutionUniversity of California San Diego
DepartmentMedicine
Address9300 Campus Point Drive #7784
La Jolla CA 92037
Phone858-246-2020
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Mahmud E, Madani MM, Kim NH, Poch D, Ang L, Behnamfar O, Patel MP, Auger WR. Chronic Thromboembolic Pulmonary Hypertension: Evolving Therapeutic Approaches for Operable and Inoperable Disease. J Am Coll Cardiol. 2018 May 29; 71(21):2468-2486. PMID: 29793636.
      View in: PubMed
    2. Smitson CC, Ang L, Pourdjabbar A, Reeves R, Patel M, Mahmud E. Safety and Feasibility of a Novel, Second-Generation Robotic-Assisted System for Percutaneous Coronary Intervention: First-in-Human Report. J Invasive Cardiol. 2018 Apr; 30(4):152-156. PMID: 29335386.
      View in: PubMed
    3. Mahmud E, Behnamfar O, Ang L, Patel MP, Poch D, Kim NH. Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension. Interv Cardiol Clin. 2018 Jan; 7(1):103-117. PMID: 29157517.
      View in: PubMed
    4. Walters D, Reeves R, Ang L, Pourdjabbar A, Mahmud E. A Bleeding Heart: Coronary-Cameral Fistula After Septal Myomectomy. J Invasive Cardiol. 2017 Dec; 29(12):E199-E200. PMID: 29207370.
      View in: PubMed
    5. Ang L, Behnamfar O, Palakodeti S, Lin F, Pourdjabbar A, Patel MP, Reeves RR, Mahmud E. Elevated Baseline Serum Fibrinogen: Effect on 2-Year Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention. J Am Heart Assoc. 2017 Nov 18; 6(11). PMID: 29151032.
      View in: PubMed
    6. Harrison J, Ang L, Naghi J, Behnamfar O, Pourdjabbar A, Patel MP, Reeves RR, Mahmud E. Robotically-assisted percutaneous coronary intervention: Reasons for partial manual assistance or manual conversion. Cardiovasc Revasc Med. 2017 Nov 09. PMID: 29221959.
      View in: PubMed
    7. Pourdjabbar A, Ang L, Behnamfar O, Patel MP, Reeves RR, Campbell PT, Madder RD, Mahmud E. Robotics in percutaneous cardiovascular interventions. Expert Rev Cardiovasc Ther. 2017 Nov; 15(11):825-833. PMID: 28914558.
      View in: PubMed
    8. Mahmud E, Pourdjabbar A, Ang L, Behnamfar O, Patel MP, Reeves RR. Robotic technology in interventional cardiology: Current status and future perspectives. Catheter Cardiovasc Interv. 2017 Nov 15; 90(6):956-962. PMID: 28795481.
      View in: PubMed
    9. Pourdjabbar A, Wilkinson MJ, Ang L, Reeves RR, Mahmud E, Patel MP. Inappropriate ICD Shock From Perceived Ventricular Fibrillation During Balloon Manipulation at the Time of Percutaneous Coronary Intervention. J Invasive Cardiol. 2017 Aug; 29(8):E94-E95. PMID: 28756425.
      View in: PubMed
    10. Pourdjabbar A, Ang L, Reeves RR, Patel MP, Mahmud E. The Development of Robotic Technology in Cardiac and Vascular Interventions. Rambam Maimonides Med J. 2017 07 31; 8(3). PMID: 28459664.
      View in: PubMed
    11. Mahmud E, Naghi J, Ang L, Harrison J, Behnamfar O, Pourdjabbar A, Reeves R, Patel M. Demonstration of the Safety and Feasibility of Robotically Assisted Percutaneous Coronary Intervention in Complex Coronary Lesions: Results of the CORA-PCI Study (Complex Robotically Assisted Percutaneous Coronary Intervention). JACC Cardiovasc Interv. 2017 Jul 10; 10(13):1320-1327. PMID: 28683937.
      View in: PubMed
    12. Cui S, Li K, Ang L, Liu J, Cui L, Song X, Lv S, Mahmud E. Plasma Phospholipids and Sphingolipids Identify Stent Restenosis After Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2017 Jul 10; 10(13):1307-1316. PMID: 28624380.
      View in: PubMed
    13. Wilkinson MJ, Ma GS, Yeang C, Ang L, Strachan M, DeMaria AN, Tsimikas S, Cotter B. The Prevalence of Lipoprotein(a) Measurement and Degree of Elevation Among 2710 Patients With Calcific Aortic Valve Stenosis in an Academic Echocardiography Laboratory Setting. Angiology. 2017 Oct; 68(9):795-798. PMID: 28068801.
      View in: PubMed
    14. Pourdjabbar A, Reeves RR, Mahmud E, Ang L, Patel MP. Technique of delayed endovascular hemostatic closure for large bore vascular access site: A case series. Cardiovasc Revasc Med. 2017 Apr - May; 18(3):215-220. PMID: 27743820.
      View in: PubMed
    15. Naghi J, Yalvac EA, Pourdjabbar A, Ang L, Bahadorani J, Reeves RR, Mahmud E, Patel M. New developments in the clinical use of drug-coated balloon catheters in peripheral arterial disease. Med Devices (Auckl). 2016; 9:161-74. PMID: 27418859; PMCID: PMC4935119.
    16. Mahmud E, Behnamfar O, Lin F, Reeves R, Patel M, Ang L. Elevated Serum Fibrinogen Is Associated With 12-Month Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention. J Am Coll Cardiol. 2016 May 31; 67(21):2556-7. PMID: 27230054.
      View in: PubMed
    17. Mahmud E, Ramsis M, Behnamfar O, Enright K, Huynh A, Kaushal K, Palakodeti S, Li S, Teh P, Lin F, Reeves R, Patel M, Ang L. Effect of Serum Fibrinogen, Total Stent Length, and Type of Acute Coronary Syndrome on 6-Month Major Adverse Cardiovascular Events and Bleeding After Percutaneous Coronary Intervention. Am J Cardiol. 2016 May 15; 117(10):1575-1581. PMID: 27040574.
      View in: PubMed
    18. Reeves RR, Ang L, Bahadorani J, Naghi J, Dominguez A, Palakodeti V, Tsimikas S, Patel MP, Mahmud E. Invasive Cardiologists Are Exposed to Greater Left Sided Cranial Radiation: The BRAIN Study (Brain Radiation Exposure and Attenuation During Invasive Cardiology Procedures). JACC Cardiovasc Interv. 2015 Aug 17; 8(9):1197-1206. PMID: 26292583.
      View in: PubMed
    19. Naghi J, Palakodeti S, Ang L, Reeves R, Patel M, Mahmud E. Renal frame count: a measure of renal flow that predicts success of renal artery stenting in hypertensive patients. Catheter Cardiovasc Interv. 2015 Aug; 86(2):304-9. PMID: 26198066.
      View in: PubMed
    20. Ang L, Mahmud E. Elevated serum fibrinogen: an independent link between diabetes mellitus, impaired on-clopidogrel platelet inhibition, and major adverse cardiac events after percutaneous coronary intervention. J Am Coll Cardiol. 2015 Apr 28; 65(16):1713-1714. PMID: 25908081.
      View in: PubMed
    21. Lee MS, Mahmud E, Ang L, Lluri G, Cheng RK, Aragon J, Sheiban I. Comparison of sirolimus-, paclitaxel-, and everolimus-eluting stent in unprotected left main coronary artery percutaneous coronary intervention. J Saudi Heart Assoc. 2013 Apr; 25(2):75-8. PMID: 24174850; PMCID: PMC3809457.
    22. Ang L, Thani KB, Ilapakurti M, Lee MS, Palakodeti V, Mahmud E. Elevated plasma fibrinogen rather than residual platelet reactivity after clopidogrel pre-treatment is associated with an increased ischemic risk during elective percutaneous coronary intervention. J Am Coll Cardiol. 2013 Jan 08; 61(1):23-34. PMID: 23287370.
      View in: PubMed
    23. Mahmud E, Ang L. Platelet function testing in practice: a case study. Rev Cardiovasc Med. 2011; 12 Suppl 1:S34-9. PMID: 22080985.
      View in: PubMed
    24. Ang L, Palakodeti V, Khalid A, Tsimikas S, Idrees Z, Tran P, Clopton P, Zafar N, Bromberg-Marin G, Keramati S, Mahmud E. Elevated plasma fibrinogen and diabetes mellitus are associated with lower inhibition of platelet reactivity with clopidogrel. J Am Coll Cardiol. 2008 Sep 23; 52(13):1052-9. PMID: 18848137.
      View in: PubMed
    25. Ang L, Mahmud E. Monitoring oral antiplatelet therapy: is it justified? Ther Adv Cardiovasc Dis. 2008 Dec; 2(6):485-96. PMID: 19124443.
      View in: PubMed
    26. Mahmud E, Bromberg-Marin G, Palakodeti V, Ang L, Creanga D, Demaria AN. Clinical efficacy of drug-eluting stents in diabetic patients: a meta-analysis. J Am Coll Cardiol. 2008 Jun 24; 51(25):2385-95. PMID: 18565394.
      View in: PubMed
    27. Mahmud E, Smith TW, Palakodeti V, Zaidi O, Ang L, Mitchell CR, Zafar N, Bromberg-Marin G, Keramati S, Tsimikas S. Renal frame count and renal blush grade: quantitative measures that predict the success of renal stenting in hypertensive patients with renal artery stenosis. JACC Cardiovasc Interv. 2008 Jun; 1(3):286-92. PMID: 19463314.
      View in: PubMed
    28. Mahmud E, Cavendish JJ, Tsimikas S, Ang L, Nguyen C, Bromberg-Marin G, Schnyder G, Keramati S, Palakodeti V, Penny WF, DeMaria AN. Elevated plasma fibrinogen level predicts suboptimal response to therapy with both single- and double-bolus eptifibatide during percutaneous coronary intervention. J Am Coll Cardiol. 2007 Jun 05; 49(22):2163-71. PMID: 17543636.
      View in: PubMed
    29. Mahmud E, Ang L. Monitoring antiplatelet therapy during peripheral vascular and coronary interventions. Tech Vasc Interv Radiol. 2006 Jun; 9(2):56-63. PMID: 17482101.
      View in: PubMed
    Lawrence's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _